Bruni, S., Mauro, F. L., Proietti Anastasi, C. J., Cordo Russo, R. I., Rivas, M. A., Inurrigarro, G., . . . Schillaci, R. (2023). Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression. Web
Citación estilo ChicagoBruni, Sofia, et al. Blocking Soluble TNFα Sensitizes HER2-positive Breast Cancer to Trastuzumab Through MUC4 Downregulation and Subverts Immunosuppression. 2023.
Cita MLABruni, Sofia, et al. Blocking Soluble TNFα Sensitizes HER2-positive Breast Cancer to Trastuzumab Through MUC4 Downregulation and Subverts Immunosuppression. 2023.
Precaución: Estas citas no son 100% exactas.